NCT05422911
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05422911
Title Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors James J. Peters Veterans Affairs Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
VA Greater Los Angeles Healthcare System RECRUITING Los Angeles California 90073 United States Details
James A. Haley Veterans Administration Hospital RECRUITING Tampa Florida 33612 United States Details
VA Ann Arbor Healthcare System RECRUITING Ann Arbor Michigan 48105 United States Details
VA St. Louis Health Care System RECRUITING St Louis Missouri 63106 United States Details
VA New York Harbor Healthcare System RECRUITING New York New York 10010 United States Details
James J. Peters VA Medical Center RECRUITING The Bronx New York 10468 United States Details
VA Hudson Valley Health Care System RECRUITING Wappingers Falls New York 12590 United States Details
W.G. Bill Hefner Medical Center RECRUITING Salisbury North Carolina 28144 United States Details
VA Portland Health Care System RECRUITING Portland Oregon 97239 United States Details
Corporal Michael J. Crescenz VA Medical Center RECRUITING Philadelphia Pennsylvania 19104 United States Details
Michael E. DeBakey VA Medical Center RECRUITING Houston Texas 77030 United States Details
VA Puget Sound Health Care System RECRUITING Seattle Washington 98108 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field